$JFTH
Japan Food Tech Holdings, Inc. Stock $jfth

$jfth Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000159991624000226 Filed on October 01, 2024

Income Statement

Concept	2024 Q2
Revenue	$5.276K
YoY Change	756.49%
Cost Of Revenue
YoY Change
Gross Profit	$5.524K
YoY Change	796.75%
Gross Profit Margin	104.7%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$88.01K
YoY Change	25.2%
Operating Profit	-$82.48K
YoY Change	18.38%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings	-$81.31K
YoY Change	18.94%
Net Earnings / Revenue	-1541.15%
Basic Earnings Per Share	-$0.02
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$8.116K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$17.32K
YoY Change	-97.48%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$17.32K
Total Long-Term Assets	$0.00
Total Assets	$17.32K
YoY Change	-97.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.67K
YoY Change	221.67%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$49.35K
YoY Change	-44.07%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.614M
YoY Change	81.16%
Common Stock	$9.571K
YoY Change	598.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$32.02K
YoY Change
Total Liabilities & Shareholders Equity	$17.32K
YoY Change	-97.48%

Cashflow Statement

Concept	2024 Q2
OPERATING ACTIVITIES
Net Income	-$81.31K
YoY Change	18.94%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$75.92K
YoY Change	314.19%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$76.25K
YoY Change	-63.61%
NET CHANGE
Cash From Operating Activities	-$75.92K
Cash From Investing Activities
Cash From Financing Activities	$76.25K
Net Change In Cash	-$625.00
YoY Change	-100.77%
FREE CASH FLOW
Cash From Operating Activities	-$75.92K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2024Q2	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q2	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001857910
CY2024Q2	us-gaap	Deferred Revenue DeferredRevenue		usd
CY2023Q2	DRFS	Revenuesrelatedparty Revenuesrelatedparty		usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2024Q2	DRFS	Creditlossesrelatedparty Creditlossesrelatedparty		usd
CY2023Q2	DRFS	Otherincomeduration Otherincomeduration		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	DRFS	Dividendvalue Dividendvalue		usd
CY2024Q2	DRFS	Preferredconvertedvalue Preferredconvertedvalue		usd
CY2024Q2	DRFS	Dividendvaluepreferredconv Dividendvaluepreferredconv		usd
CY2024Q2	DRFS	Interestreceivableperiodrleatedparty Interestreceivableperiodrleatedparty		usd
CY2024Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities		usd
CY2023Q2	us-gaap	Deferred Revenue Period Increase Decrease DeferredRevenuePeriodIncreaseDecrease		usd
CY2024Q2	DRFS	Loantorelatedpartyincreasedecrease Loantorelatedpartyincreasedecrease		usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2024Q2	DRFS	Cashreceivedforcommonstock Cashreceivedforcommonstock		usd
CY2024Q2	us-gaap	Interest Paid InterestPaid		usd
CY2023Q2	us-gaap	Interest Paid InterestPaid		usd
CY2024Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q2	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2023Q2	DRFS	Deemeddivonpreferredstock Deemeddivonpreferredstock		usd
CY2024Q2	DRFS	Commonparvalueasof Commonparvalueasof	0.0001	usd
CY2024Q2	dei	Document Type DocumentType	10-Q
CY2024Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q2	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024Q2	dei	Entity File Number EntityFileNumber	000-56277
CY2024Q2	dei	Entity Registrant Name EntityRegistrantName	Japan Food Tech Holdings, Inc.
CY2024Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	00-0000000
CY2024Q2	dei	Local Phone Number LocalPhoneNumber	81-90-6002-4978
CY2024Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q2	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q2	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q2	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	95708699	shares
CY2024Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	9918	shares
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8116	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8741	usd
CY2024Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	5786	usd
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	11333	usd
CY2024Q2	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	3422	usd
CY2024Q1	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	1532	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	17324	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	21606	usd
CY2024Q2	us-gaap	Assets Assets	17324	usd
CY2024Q1	us-gaap	Assets Assets	21606	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	14668	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1017	usd
CY2024Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	34649	usd
CY2024Q1	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	48142	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	328	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	30	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	532	usd
CY2024Q2	us-gaap	Liabilities Liabilities	49347	usd
CY2024Q1	us-gaap	Liabilities Liabilities	50019	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	9918	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	10000	shares
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4800000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	95708699	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13708699	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	9571	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	1371	usd
CY2024Q2	DRFS	Foreigncurrencytranslationadjustment Foreigncurrencytranslationadjustment	-67795	usd
CY2024Q1	DRFS	Foreigncurrencytranslationadjustment Foreigncurrencytranslationadjustment	-69245	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2640396	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2175985	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2614196	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2136525	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-32023	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-28413	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17324	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21606	usd
CY2024Q2	us-gaap	Revenues Revenues	5276	usd
CY2023Q2	us-gaap	Revenues Revenues	616	usd
CY2024Q2	DRFS	Revenuesrelatedparty Revenuesrelatedparty	248	usd
CY2024Q2	DRFS	Totalrevenues Totalrevenues	5524	usd
CY2023Q2	DRFS	Totalrevenues Totalrevenues	616	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	5524	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	616	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	88008	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	70293	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	88008	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	70293	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-82484	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-69677	usd
CY2023Q2	DRFS	Creditlossesrelatedparty Creditlossesrelatedparty	1315	usd
CY2024Q2	DRFS	Otherincomeduration Otherincomeduration	1173	usd
CY2024Q2	DRFS	Interest And Other Incometotal InterestAndOtherIncometotal	1173	usd
CY2023Q2	DRFS	Interest And Other Incometotal InterestAndOtherIncometotal	1315	usd
CY2024Q2	DRFS	Netincomelossbeforetax Netincomelossbeforetax	-81311	usd
CY2023Q2	DRFS	Netincomelossbeforetax Netincomelossbeforetax	-68362	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-81311	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-68362	usd
CY2024Q2	DRFS	Dividendvalue Dividendvalue	-396360	usd
CY2024Q2	DRFS	Netincomeattributabletoshareholder Netincomeattributabletoshareholder	-477671	usd
CY2023Q2	DRFS	Netincomeattributabletoshareholder Netincomeattributabletoshareholder	-68362	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1450	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-45112	usd
CY2024Q2	DRFS	Total Comprehensive Income Loss Tax TotalComprehensiveIncomeLossTax	-79861	usd
CY2023Q2	DRFS	Total Comprehensive Income Loss Tax TotalComprehensiveIncomeLossTax	-113474	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2024Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	26324084	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	13278023	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13708699	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	10000	shares
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-28413	usd
CY2024Q2	DRFS	Proceeds From Contributions ProceedsFromContributions	76251	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-81311	usd
CY2024Q2	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	1450	usd
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	95708699	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	9918	shares
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-32023	usd
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13114888	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	10000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13708699	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	10000	shares
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-81311	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-68362	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	5031	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-1914	usd
CY2024Q2	DRFS	Advancepayments Advancepayments	-2048	usd
CY2023Q2	DRFS	Advancepayments Advancepayments	550	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	14171	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2013	usd
CY2024Q2	DRFS	Increase Decrease In Accounts Payablerelatedparty IncreaseDecreaseInAccountsPayablerelatedparty	-10961	usd
CY2023Q2	DRFS	Increase Decrease In Accounts Payablerelatedparty IncreaseDecreaseInAccountsPayablerelatedparty	57707	usd
CY2023Q2	DRFS	Interestreceivableperiodrleatedparty Interestreceivableperiodrleatedparty	-1315	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2705	usd
CY2024Q2	us-gaap	Deferred Revenue Period Increase Decrease DeferredRevenuePeriodIncreaseDecrease	-318	usd
CY2024Q2	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-485	usd
CY2023Q2	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-278	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-75921	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18330	usd
CY2023Q2	DRFS	Loantorelatedpartyincreasedecrease Loantorelatedpartyincreasedecrease	-109099	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-109099	usd
CY2023Q2	DRFS	Cashreceivedforcommonstock Cashreceivedforcommonstock	187050	usd
CY2024Q2	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	76251	usd
CY2023Q2	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	22496	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	76251	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	209546	usd
CY2024Q2	DRFS	Neteffectofexchangeratechangesoncash Neteffectofexchangeratechangesoncash	-955	usd
CY2023Q2	DRFS	Neteffectofexchangeratechangesoncash Neteffectofexchangeratechangesoncash	-1187	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-625	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	80930	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8741	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1365	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8116	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	82295	usd
CY2024Q2	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	8200	usd
CY2024Q2	DRFS	Deemeddivonpreferredstock Deemeddivonpreferredstock	396360	usd
CY2024Q2	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_843_eus-gaap--UseOfEstimates_zVowLObjFRzd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_86E_ziE3a3WmeYc7" style="font-family: Times New Roman, Times, Serif; color: #000000; background-color: white"><b>Use of Estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: #000000">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary to make the financial statements not misleading have been included. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: #000000"> </span></p>
CY2024Q2	DRFS	Advertisingandpromotion Advertisingandpromotion	<p id="xdx_84D_ecustom--Advertisingandpromotion_zQrNuIpmrDF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #212529"><span style="background-color: white"><b><span id="xdx_86E_zg0m1Qcz9RBa">Advertising and Promotion</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #212529"><span style="background-color: white">All advertising, promotion and marketing expenses, including commissions, are expensed when incurred. Advertising expenses totaled $<span id="xdx_903_ecustom--Advertisingandpromotionexpenses_c20240401__20240630_ztpaM6Gs6vyj" title="advertising and promotion">12,808</span> and $<span id="xdx_904_ecustom--Advertisingandpromotionexpenses_c20230401__20230630_zNnSdScaKfA5" title="advertising and promotion">14,081</span> for the periods ended June 30, 2024 and 2023, respectively.</span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: #000000"> </span></p>
CY2024Q2	DRFS	Advertisingandpromotionexpenses Advertisingandpromotionexpenses	12808	usd
CY2023Q2	DRFS	Advertisingandpromotionexpenses Advertisingandpromotionexpenses	14081	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8116	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8741	usd
CY2024Q2	DRFS	Accountsreceivableandcreditpoliciestextblock Accountsreceivableandcreditpoliciestextblock	<p id="xdx_845_ecustom--Accountsreceivableandcreditpoliciestextblock_z3Fu1rbxSIr9" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_86D_zAKuZyPzGj7a">Accounts Receivable and Credit Policies</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Accounts receivable are recognized and carried at the original invoice amount less allowance for any uncollectible amounts. An estimate for doubtful accounts is made when collection of the full amount is no longer probable. Bad debts are written off as incurred. Accounts receivable totaled $<span id="xdx_90F_ecustom--Totalaccountsreceivable_iI_c20240630_ztWOWGQeqlkh">5,786 </span>and $<span id="xdx_90E_ecustom--Totalaccountsreceivable_iI_c20240331_zynYAIOlYew9">11,333</span> as of June 30, 2024 and March 31, 2024, respectively. Allowances for doubtful accounts were $0 for both periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2024Q2	DRFS	Totalaccountsreceivable Totalaccountsreceivable	5786	usd
CY2024Q1	DRFS	Totalaccountsreceivable Totalaccountsreceivable	11333	usd
CY2024Q2	DRFS	Concentrationcreditriskpolicy Concentrationcreditriskpolicy	<p id="xdx_845_ecustom--Concentrationcreditriskpolicy_zmjtnUoj4zUf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span id="xdx_865_zudeduGPKNxd"><b>Concentration of Credit Risk</b></span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529">Accounts receivable from customers accounting for 10% or more of total accounts receivable are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"> </p> <p style="font: 11pt Aptos; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">For the period ended June 30, 2024, 95% of total accounts receivable was owed by five customers in the amount of $<span id="xdx_90A_ecustom--Totalaccountsreceivableperiod_c20240401__20240630_zJ1mm2ZYtRJj" title="total accounts receivable">5,514</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529">For the year ended March 31, 2024, 84% of total accounts receivable was owed by one customer in the amount of $<span id="xdx_90D_ecustom--Totalaccountsreceivableperiod_c20230401__20240331_zSES72Wt0jUf" title="total accounts receivable">9,467</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p>
CY2024Q2	DRFS	Totalaccountsreceivableperiod Totalaccountsreceivableperiod	5514	usd
CY2024	DRFS	Totalaccountsreceivableperiod Totalaccountsreceivableperiod	9467	usd
CY2024Q2	us-gaap	Revenue Recognition Accounting Policy Gross And Net Revenue Disclosure RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure	<p id="xdx_849_eus-gaap--RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure_zUYKuNY3ecF9" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_86C_zS9WEVQCJg8d"><b>Revenue Recognition</b></span><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="background-color: white">The Company adopted ASC 606, <i>Revenue from Contracts with Customers</i> (Topic 606) (“ASC 606”), in the third quarter of fiscal year 2023, as this was the first quarter that the Company generated revenues. Under ASC 606, the Company recognizes revenue when a customer obtains control of promised goods, in an amount that reflects the consideration that the Company expects to receive in exchange for the goods. To determine revenue recognition for arrangements within the scope of ASC 606, the Company performs the following five steps: (1) identify the contracts with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when or as the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods it transfers to the customer. Under ASC 606, disaggregated revenue from contracts with customers depicts the nature, amount, timing, and uncertainty of revenue and cash flows affected by economic factors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="background-color: white"><i><span style="text-decoration: underline">Revenue from product sales</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="background-color: white">We recognize revenue upon transfer of control of our promised goods in an amount that reflects the consideration we expect to be entitled to in exchange for those goods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="background-color: white">For our primary transaction-based revenue source we have determined we are acting as an agent in the transactions and, therefore, a net presentation (that is, the amount billed to a customer less the amount paid to a supplier). Net presentation is appropriate for the majority of our revenue transactions as the supplier is primarily responsible for providing the underlying goods and services and we do not control the goods provided by the supplier to the customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="background-color: white">Revenue for products is recognized when the products are delivered to the customer and the customer completes the product inspection. Cash receipts for undelivered products are recorded as deferred revenues. As of June 30, 2024 and March 31, 2024, the Company had deferred revenues related to product sales of $0 and $328, respectively. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="background-color: white">The Company’s revenue consists of food product sales through its subsidiary, Dr. Foods Co., Ltd. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="background-color: white"><i><span style="text-decoration: underline">Revenue - related party</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="background-color: white">During the periods ended June 30, 2024 and June 30, 2023, revenue totaling approximately $248 and $0, respectively, was recognized from sales to related party WB Burgers Japan Co. Ltd. (hereinafter referred to as “WBBJ”). WBBJ is considered to be a related party due to the fact that Koichi Ishizuka, CEO of the Company, indirectly controls WBBJ through his share ownership of WB Burgers Asia, Inc. The terms and conditions applied to the above transactions were the same as those applied to sales to customers not related to the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="background-color: white">The Company’s revenue consists of food product sales through its subsidiary, Dr. Foods Co., Ltd. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="background-color: white"> </span></p>
CY2024Q2	DRFS	Revenueconcentrationpolicy Revenueconcentrationpolicy	<p id="xdx_846_ecustom--Revenueconcentrationpolicy_z4qeZpUX6Zw6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="background-color: white"><b><span id="xdx_86E_z3qt0dmipY5d">Concentration of Revenues</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="background-color: white">Gross revenues from customers accounting for 10% or more of total revenues are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"> </p> <p style="font: 11pt Aptos; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529; background-color: white">For the period ended June 30, 2024, 83% of total revenue was generated from three customers in the amount of $4,379</span><span style="font-size: 8pt"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529; background-color: white">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"> </p>
CY2024Q2	DRFS	Researchanddevelopmentdisclosure Researchanddevelopmentdisclosure	<p id="xdx_84D_ecustom--Researchanddevelopmentdisclosure_zobunstTagOd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #212529"><span style="background-color: white"><b><span id="xdx_867_zVrrv8OwlyV8">Research and Development Expense</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #212529"><span style="background-color: white">Research and development expense consists of costs incurred in performing research and development activities, including compensation and benefits for related employees, outside services and consulting costs, and related facilities, information technology and overhead expenses. Research and development costs are expensed as incurred. Research and development expenses totaled $0 in the periods ended June 30, 2024 and 2023.</span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: #000000"> </span></p>
CY2024Q1	DRFS	Netlossasof Netlossasof	2217836	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	465746	usd
CY2024Q2	DRFS	Commonsharesauthorizedasof Commonsharesauthorizedasof	4800000000	shares
CY2024Q2	DRFS	Commonsharesoutstandingasof Commonsharesoutstandingasof	95708699	shares
CY2024Q1	DRFS	Commonsharesoutstandingasof Commonsharesoutstandingasof	13708699	shares
CY2024Q2	DRFS	Paidbysoleofficer Paidbysoleofficer	76251	usd
CY2023Q2	DRFS	Paidbysoleofficer Paidbysoleofficer	22496	usd
CY2024Q2	DRFS	Salesduringperiodtowbbj Salesduringperiodtowbbj	248	usd
CY2023Q2	DRFS	Salesduringperiodtowbbj Salesduringperiodtowbbj	0	usd
CY2024Q1	DRFS	Invoicesfrommama Invoicesfrommama	8984	usd
CY2024Q2	DRFS	Invoicesfrommama Invoicesfrommama	4263	usd
CY2024Q1	DRFS	Invoicesfromnmco Invoicesfromnmco	14031	usd
CY2024Q2	DRFS	Invoicesfromnmco Invoicesfromnmco	40054	usd
CY2024Q2	DRFS	Paymentstonmco Paymentstonmco	47319	usd
CY2024Q2	DRFS	Totalowedtonmcoasof Totalowedtonmcoasof	6766	usd
CY2024Q1	DRFS	Invoicesfromwk Invoicesfromwk	7120	usd
CY2024Q1	DRFS	Totalowedtowkasof Totalowedtowkasof	25127	usd
CY2024Q2	DRFS	Totalowedtowkasof Totalowedtowkasof	23620	usd
CY2024Q2	DRFS	Expensespaidbysoleofficer Expensespaidbysoleofficer	76251	usd
	DRFS	Expensespaidbysoleofficer Expensespaidbysoleofficer	22496	usd
CY2024Q1	DRFS	Paymentsforunfulfilledorders Paymentsforunfulfilledorders	328	usd

Files In Submission

Name	View Source	Status
0001599916-24-000226-index-headers.html	Edgar Link	pending
0001599916-24-000226-index.html	Edgar Link	pending
0001599916-24-000226.txt	Edgar Link	pending
0001599916-24-000226-xbrl.zip	Edgar Link	pending
drfs-20240630.xsd	Edgar Link	pending
drfs_q125o.htm	Edgar Link	pending
exhibit31.htm	Edgar Link	pending
exhibit32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
drfs-20240630_cal.xml	Edgar Link	unprocessable
drfs-20240630_def.xml	Edgar Link	unprocessable
drfs-20240630_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
drfs_q125o_htm.xml	Edgar Link	completed
drfs-20240630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JFTH
Japan Food Tech Holdings, Inc. Stock $jfth

2024 Q2 Form 10-Q Financial Statement

#000159991624000226 Filed on October 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JFTH Japan Food Tech Holdings, Inc. Stock $jfth

2024 Q2 Form 10-Q Financial Statement

#000159991624000226 Filed on October 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JFTH
Japan Food Tech Holdings, Inc. Stock $jfth